Top Markets
Coin of the day
Nanjing Hicin Pharmaceutical Co., Ltd. Nanjing Hicin Pharmaceutical Co., Ltd.

Nanjing Hicin Pharmaceutical Co., Ltd.

300584
株式のランク #12879
Nanjing Hicin Pharmaceutical Co., Ltd. (NHPC), established in 2003 and... Nanjing Hicin Pharmaceutical Co., Ltd. (NHPC), established in 2003 and headquartered in Nanjing, China, operates as a comprehensive enterprise specializing in the research, development, production, marketing, and distribution of pharmaceutical preparations and synthetic chemicals within China. The company boasts a diverse product portfolio, addressing various therapeutic areas such as antivirals, antibiotics, endocrine regulators, gastrointestinal treatments, orthopedic medications, cardiovascular and cerebrovascular drugs, and immunomodulatory agents. Beyond its core pharmaceutical activities, NHPC also provides technology transfer services. On an international scale, Nanjing Hicin Pharmaceutical Co., Ltd. is a supplier of Active Pharmaceutical Ingredients (APIs). Its export offerings specifically include injectable forms of omeprazole sodium and cefepime hydrochloride, along with lansoprazole tablets, which reach markets across South Asia, South America, and Europe.
株価
$4.51
時価総額
$540.82M
変化(1日)
-2.42%
変化(1年)
-43.50%
CN
取引 Nanjing Hicin Pharmaceutical Co., Ltd. (300584)

カテゴリー

Nanjing Hicin Pharmaceutical Co., Ltd.(300584)の配当利回りの履歴
Nanjing Hicin Pharmaceutical Co., Ltd.(銘柄コード: 300584)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Nanjing Hicin Pharmaceutical Co., Ltd.(300584)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)